MyFinsight
Home
About
Contact
dna: the income statement
Download
Download image
Unrealized gains (loss) on
available-for-sale securities
$316K
Foreign currency
translation adjustment
$27K
(-94.53%↓ Y/Y)
Comprehensive loss
-$80,412K
(-47.77%↓ Y/Y)
Total other
comprehensive (loss) income
$343K
Net loss
-$80,755K
(-43.18%↓ Y/Y)
Gain (loss) on
investments
$3,684K
(153.30%↑ Y/Y)
Interest income, net
$5,742K
(162.07%↑ Y/Y)
General and
administrative
$6,692K
Cost of biosecurity
revenue
$7,643K
General and
administrative
$12,170K
Research and development
$50,954K
Cost of biosecurity
revenue
$2,994K
Income tax (benefit)
expense
$1K
(100.27%↑ Y/Y)
Loss before income
taxes
-$80,754K
(-42.23%↓ Y/Y)
Total other income
(expense)
$9,263K
(688.50%↑ Y/Y)
Biosecurity Segment
$9,457K
Cell Engineering
Segment
$29,380K
Other income
(expense), net
-$163K
(-110.37%↓ Y/Y)
Loss from operations
-$4,878K
Loss from operations
-$36,738K
Loss from operations
-$90,017K
(-63.06%↓ Y/Y)
Total revenue
$38,837K
(-56.39%↓ Y/Y)
Total operating
expenses
$128,854K
(-10.67%↓ Y/Y)
Restructuring charges
$1,745K
General and
administrative
$44,954K
Research and development
$69,353K
Cost of biosecurity
revenue-Other Revenue
$4,625K
Cost of biosecurity
revenue-Biosecurity
$8,177K
Back
Back
Income Statement
source: myfinsight.com
Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. (DNA)